BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY) for BLOOD CANCER UNITED (FKA THE LEUKEMIA & LYMPHOMA SOCIETY)
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
HR 1262 / S 932, Give Kids a Chance Act; HR 3521, Clinical Trial Modernization Act; HR 2571, Self-insurance Protection Act; HR 247 / S 46, Health Care Affordability Act; HR 4317, PBM Reform Act; HR 1834, Breaking the Gridlock Act; S 2420, No Surprises Act Enforcement Act; HR 3521, the Clinical Trial Modernization Act; S 2355, the Patients Deserve Price Tags Act; Proposals related to the 2027 FDA user fee agreements; Proposals to extend enhanced Advanced Premium Tax Credits; Regulations to implement the No Surprises Act; Issues related to the cost of care, including consolidation and anti-competitive contracting
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE ANN BERGE | — |
| JESSICA BURNELL | — |
| BRIAN CONNELL | — |
| MATTHEW MARKS | — |
Medicare/Medicaid MMM
HR 1509 / S 752, Accelerating Kids Access to Care Act (AKACA); S 2497, Fair Billing Act; S 1629, Same Care, Lower Cost Act; HR 7148, Consolidated Appropriations Act, specifically provisions related to Medicaid provider enrollment and a Medicare unique provider identifier requirement for hospital outpatient billing
| Lobbyist | Covered position, as disclosed |
|---|---|
| KATIE ANN BERGE | — |
| JESSICA BURNELL | — |
| BRIAN CONNELL | — |
| MATTHEW MARKS | — |
Budget/Appropriations BUD
HR 7148, the Consolidated Appropriations Act, specifically provisions related to medical research funding; FY2027 appropriations for HHS and DOD, specifically provisions related to medical research funding;
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN CONNELL | — |
| MATTHEW MARKS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.